search for


Comparison of short-term outcomes of open and laparoscopic assisted pancreaticoduodenectomy for periampullary carcinoma: A propensity score-matched analysis
Ann Hepatobiliary Pancreat Surg 2024 May;28(2):220-8
Published online May 31, 2024;
Copyright © 2024 The Korean Association of Hepato-Biliary-Pancreatic Surgery.

Utpal Anand, Rohith Kodali, Kunal Parasar, Basant Narayan Singh, Kislay Kant, Sitaram Yadav, Saad Anwar, Abhishek Arora

Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Patna, India
Correspondence to: Rohith Kodali, MS
Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Patna 801507, India
Tel: +91-842-024-0526, E-mail:
Received November 7, 2023; Revised January 28, 2024; Accepted January 30, 2024.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Backgrounds/Aims: Postoperative pancreatic fistula is the key worry in the ongoing debate about the safety and effectiveness of total laparoscopic pancreaticoduodenectomy (TLPD). Laparoscopic-assisted pancreaticoduodenectomy (LAPD), a hybrid approach combining laparoscopic resection and anastomosis with a small incision, is an alternative to TLPD. This study compares the short-term outcomes and oncological efficacy of LAPD vs. open pancreaticoduodenectomy (OPD).
Methods: A retrospective analysis of data of all patients who underwent LAPD or OPD for periampullary carcinoma at a tertiary care center in Northeast India from July 2019 to August 2023 was done. A total of 30 LAPDs and 30 OPDs were compared after 1:1 propensity score matching. Demographic data, intraoperative and postoperative data (30 days), and pathological data were compared.
Results: The study included a total of 93 patients, 30 underwent LAPD and 62 underwent OPD. After propensity score matching, the matched cohort included 30 patients in both groups. The LAPD presented several advantages over the OPD group, including a shorter incision length, reduced postoperative pain, earlier initiation of oral feeding, and shorter hospital stays. LAPD was not found to be inferior to OPD in terms of pancreatic fistula incidence (Grade B, 30.0% vs. 33.3%), achieving R0 resection (100% vs. 93.3%), and the number of lymph nodes harvested (12 vs. 14, p = 0.620). No significant differences in blood loss, short-term complications, pathological outcomes, readmissions, and early (30-day) mortality were observed between the two groups.
Conclusions: LAPD has comparable safety, technical feasibility, and short-term oncological efficacy.
Keywords : Pancreaticoduodenectomy; Propensity score; Laparoscopy

Open pancreaticoduodenectomy (OPD) has been the standard of care in the surgical management of patients with periampullary carcinoma (PAC) [1,2]. However, minimally invasive surgery for PAC has grown in popularity and acceptance over the last decade with the benefits of decreased blood loss, less postoperative pain, early initiation of oral nutrition, and shorter hospital stays [3,4]. Despite advances in minimally invasive techniques, theincidence of postoperative pancreatic fistula (POPF) still ranges between 3% to 45% in high-volume institutions [5-7]. Pancreatoenteric anastomosis is considered the Achilles heel of pancreatoduodenectomy (PD); the associated morbidity andmortality of POPF outweigh the advantages of laparoscopic PD.

The laparoscopic pancreatoenteric anastomosis remains limited and its safety and efficacy remain debatable because, unlike open technique, with laparoscopic pancreatojejunostomy, it is challenging to perform precise anastomosis resulting in increased rates of POPF and restricting patient selection in the total laparoscopic pancreaticoduodenectomy (TLPD) group (small size tumor, early-stage tumor, hard pancreas, and dilated pancreatic duct). In addition, there are increased rates of other postoperative complications such as delayed gastric emptying (DGE) and post-pancreatectomy hemorrhage (PPH) [8]. Notably, the majority of the evidence on TLPD comes from high-volume centers with super-selective cases [9-11].

Laparoscopic-assisted pancreaticoduodenectomy (LAPD), is a hybrid surgery that combines the advantages of laparoscopic resection and overcomes the difficulty in performing a precise anastomosis through a small midline laparotomy avoiding the technically arduous laparoscopic reconstruction. This can serve as a bridge in the learning curve in the transition from OPD to TLPD. However, there is a scarcity of data comparing the outcomes of the LAPD and OPD [8]. The majority of data are non-randomized retrospective data and there are few high-quality comparison research studies [12-14]. This study aimed to compare short-term outcomes and oncological efficacy of the LAPD versus OPD using a propensity score matching analysis.


The medical records of all patients who had undergone PD at a tertiary care center in Northeast India between July 1, 2019 and August 31, 2023 were retrospectively reviewed. Patients included in the study had either a clinical and radiological suspicion of periampullary mass or a preoperative histological diagnosis of PAC. We initially performed OPD cases in the first two years of the study period and subsequently transitioned to LAPD. The inclusion criteria of patients in both groups were nonmetastatic, resectable PAC-encompassing pancreatic head (within 2 cm of the ampulla), duodenum, ampulla of Vater, and distal common bile duct. There were no specific inclusion criteria for the LAPD group. The resectability criteria followed the National Comprehensive Cancer Network Guidelines for pancreatic tumors using standard preoperative pancreatic protocol computerized tomography scan [15]. Patients with locally advanced disease, borderline resectable tumors (according to NCCN criteria), prior neoadjuvant therapy, and those who required vascular resection were excluded from both groups. Additionally, patients presenting with multiple comorbidities and prior major abdominal surgery were not considered for LAPD. Patients were provided with detailed information about the LAPD and OPD procedures. The operating surgeon made the final decision of LAPD versus OPD during the initial staging laparoscopy considering tumor factors and adhesions.

This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institute Ethical Board Committee, All India Institute of Medical Sciences, Patna, India (Protocol code -IEC/2022/1043). Informed consent was taken from all participants involved in the study. Following the institutional ethical committee review board approval, parameters such as patient demographics, comorbidities, preoperative blood indices, need for preoperative biliary drainage, duration of surgery after biliary drainage, intraoperative details, early postoperative outcomes, and histopathological data were analyzed between the two groups. Of the 110 PD patients 92 patients had PD done for PAC, of which 30 underwent LAPD and 62 underwent OPD, as shown in Fig. 1. To minimize the possibility of selection bias, a propensity score-matching study was carried out using logistic regression analysis. This was because variables like age, sex, body mass index (BMI), comorbidity index, preoperative pathology (PAC), biliary drainage, and clinical complaints could influence the outcome of surgery.

Fig 1. Flow diagram of patient inclusion criteria. PD, pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; LAPD, laparoscopic assisted pancreaticoduodenectomy; BMI, body mass index; SPEN, solid pseudopapillary epithelial neoplasm.

All the LAPD and OPD operations were performed by the same team of surgeons. Standard open pylorus resecting PD was performed using the bilateral subcostal approach. LAPD comprised the laparoscopic phase of mobilization, lymph nodal dissection, and specimen transection. The specimen was then placed in a specimen-extracting bag. Subsequently, reconstruction was performed through an upper midline incision of 6–7 cm, and the specimen was retrieved externally. The reconstruction technique was similar in both groups. It included two-layer duct to mucosa pancreatojejunostomy without any internal stent placement or dunking/invagination technique for nondilated pancreatic duct, single-layer interrupted hepaticojejunostomy, and ante colic two-layer gastrojejunostomy. A single abdominal drain is placed in the right subhepatic space.

Operative time was measured from the initial trocar insertion (LAPD) or skin incision (OPD) until the closure of the skin. The estimated blood loss was calculated as the total volume of fluids collected in the suction device, in addition to the weight of gauze and towels used during the procedure. The conversion from laparoscopic to an open procedure was defined as the shift to a laparotomy before reaching the dissection of mid-pancreatic tissue, without regard to the specific level of the laparotomy. Postoperative complications were evaluated following the Clavien–Dindo classification and encompassed issues such as POPF, DGE, bile leaks, PPH, intraabdominal collections, and surgical site infections. These complications were categorized into grades A, B, and C, as outlined by the International Study Group of Pancreatic Surgery (ISGPS) guidelines [16-18]. Reoperation was defined as a subsequent surgical procedure necessitated within 30 days of the LAPD due to significant complications. Morbidity and mortality refer to the occurrence of adverse health outcomes or fatal outcomes during or within 30 days after surgery. The final pathological diagnosis was established by using the American Joint Committee on Cancer (AJCC) cancer staging manual, considering the tumor’s size, grade, pathological type, lymphovascular invasion, perineural invasion, total number of lymph nodes inspected, and margin status. Surgical resections were categorized as R0 if no cancer was detected in any of the margins, R1 if cancer was discovered within 1 mm of the resected margins, and R2 if there was cancer in any of the margins. The histopathological examination of PD specimens followed the American College of Pathologists Protocol [19].

Statistical analysis

The LAPD group was compared with the OPD group in a 1:1 association. matched demographic, surgical, and postoperative characteristics were compared between the two groups using bivariate analysis. Continuous variables were presented as mean ± standard deviation or median (interquartile range [IQR]) based on the normality of the data. The Fisher exact test or Chi-square test was used to test the statistical significance of cross-tabulation of categorical variables. A t-test was used to compare the continuous variables between the two groups to ascertain their mean (standard deviation). The median (IQR) of continuous variables was compared between the two groups using the Mann–Whitney U test. A p-value < 0.05 was considered statistically significant. Data analysis was carried out using SPSS 20.0 (SPSS Inc.).


Following propensity matching, 60 patients were divided into two groups: 30 patients in the LAPD and the OPD group. Covariates were compared between the groups, before and after matching. Table 1 displays the demographic and preoperative variables for both groups before and after propensity score matching. The mean age of the patients was 49.53 ± 12.73 years in the LAPD group and 48.60 ± 10.25 years in the OPD group. The distribution of male and female patients in the LAPD and OPD groups was 36.7%, 63.3%, and 60%, 40% (p = 0.071). Jaundice and weight loss were the predominant symptoms. Preoperatively, there was no significant difference in the mean total bilirubin between the LAPD and OPD groups (11.23 [7.73 to 14.96] vs. 9.85 [6.2 to 13.8], p = 0.267). Patients’ BMI, American Society of Anesthesiologists (ASA) grade, pancreatic duct diameter, rate of preoperative biliary drainage, and Charlson comorbidity index did not differ significantly between the groups [20].

Table 1 . Comparison of demographic and preoperative parameters between two groups before and after propensity matching

ParameterAll patientAfter propensity matching

LAPD (n = 30)OPD (n = 62)p-valueLAPD (n = 30)OPD (n = 30)p-value
Age (yr)49.53 ± 12.7350.21 ± 11.530.79949.53 ± 12.7348.60 ± 10.250.756
Male11 (36.7)40 (64.5)11 (36.7)18 (60.0)
Female19 (63.3)22 (35.5)19 (63.3)12 (40.0)
BMI (kg/m2)21 (20–22)21 (20–22)0.15921 (20–22)21 (20–22)0.260
Class I18 (60.0)39 (62.9)18 (60.0)18 (60.0)
Class II11 (36.7)23 (37.1)11 (36.7)12 (40.0)
Class > III1 (3.3)0 (0)1 (3.3)0 (0)
Preoperative Hb (g/dL)10.77 ± 1.1411.38 ± 1.170.02010.77 ± 1.1411.36 ± 1.170.052
Preoperative total bilirubin (mg/dL)11.23 (7.73–14.96)11.98 (6.8–16.7)0.80911.23 (7.73–14.96)9.85 (6.2–13.8)0.267
Preoperative direct bilirubin (mg/dL)7.21 (4.4–10.4)7.55 (3.4–9.8)0.6267.21 (4.4–10.4)5.75 (3.2–8.9)0.318
Preoperative albumin (g/dL)3.34 (3.12–3.6)3.12 (2.99–3.4)0.0903.34 (3.12–3.6)3.12 (2.98–3.52)0.129
Prothrombin time (sec)15.1 ± 3.114 ± 2.550.11415.1 ± 3.113.8 ± 2.050.078
Pancreatic duct diameter (mm)4.75 (2–6)4 (3–7)0.8535 (2–6)4 (3.0–5.4)0.927
Preoperative biliary drainage22402218
ERCP16 (53.3)31 (50.0)0.76416 (53.3)14 (46.7)0.606
PTBD6 (20.0)9 (14.5)0.7146 (20.0)4 (13.3)0.488
Preoperative symptoms
Jaundice30 (100)58 (93.5)0.30030 (100)29 (96.7)0.996
Weight loss26 (86.7)62 (100)0.01026 (86.7)30 (100)0.112
Recurrent fever16 (53.3)34 (54.8)0.89216 (53.3)15 (50.0)0.998
Comorbidity index2.3 ± 1.12.2 ± 1.30.6532.3 ± 1.12.3 ± 1.40.996

Values are presented as mean ± standard deviation, number (%), mean (range), or number only.

BMI, body mass index; ASA, American Society of Anesthesiologists; ERCP, endoscopic retrograde cholangiopancreatography; PTBD, percutaneous transhepatic biliary drainage; LAPD, laparoscopic assisted pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy.

Table 2 displays the perioperative outcomes for the two groups after propensity matching. The LAPD group had a longer operative time in comparison to the OPD group 463.80 ± 40.94 vs. 359.00 ± 45.89 (p < 0.001). The LAPD group exhibited several advantages over the OPD group, including the shorter incision (6 cm vs. 17 cm, p < 0.001), less postoperative pain, visual analog scale score (5 vs. 7, p < 0.001), initiation of early oral feeding (5 days vs. 6 days, p < 0.001), and shorter hospital stays (8 days vs. 10 days, p < 0.001). No significant differences were noted in blood loss, intraoperative blood transfusions, pancreatic texture, and need for intensive care unit stay between the groups. The duration of surgery after biliary drainage was the same in both groups.

Table 2 . Comparison of perioperative outcomes between LAPD and OPD groups after propensity scoring

ParameterLAPD (n = 30)OPD (n = 30)p-value
Duration of surgery after biliary drainage (mon)2 (2–3)2 (2–2)0.315
Operative time (min)463.80 ± 40.94359.00 ± 45.89< 0.001
Intraoperative blood transfusion24 (80.0)22 (73.3)0.542
Estimated blood loss (mL)400 (300–500)350 (300–500)0.259
Pancreas texture (soft)16 (53.3)15 (50.0)0.796
Postoperative ICU stay (day)2 (2–2)2 (2–3)0.005
Time to passage of flatus (day)4 (3–4)4 (4–4)0.035
Time to oral intake (day)5 (4–6)6 (5–7)< 0.001
Length of hospital stay (day)8 (7–9)10 (9–12)< 0.001
Length of incision (cm)6 (6–7)17 (16–18)< 0.001
Postoperative pain (VAS)5 (3–6)7 (6–9)< 0.001

Values are presented as mean (range), mean ± standard deviation, or number (%).

LAPD, laparoscopic assisted pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; ICU, intensive care unit; VAS, visual analog scale.

Table 3 provides an overview of the surgical outcomes and short-term complications in the two groups following propensity matching. The short-term postoperative surgical complications, POPF, DGE, PPH, bile leak, intrabdominal collections, wound infection, and pulmonary infection, did not exhibit significant differences between the two groups. POPF was the most common complication in both groups; Grade A POPF accounted for 66.7% and 63.3% in the LAPD group and OPD group, respectively. Grade B POPF was observed in 30% of the LAPD cases and 33.3% in the OPD cases, but there were no instances of Grade C POPF. DGE was the second most common complication. Grade A DGE accounted for 36.7% and 33.3% in the LAPD and OPD groups, respectively, and it responded well to conservative measures and prokinetic agents. Grade B DGE occurred in 30% of LAPD cases and 50% of OPD cases. A total of 9 patients in the LAPD group and 13 in the OPD group with Grade B DGE had an intraabdominal collection that required an additional image-guided percutaneous drainage. Two patients in each group experienced bile leaks, which spontaneously resolved. In the OPD group, postoperative bleeding was observed in three patients due to bleeding from the gastroduodenal artery (GDA) stump, pancreatic cut surface, and small bowel mesentery. Postoperative bleeding occurred early in 2 patients (< 24 hours) and 1 patient had delayed presentation (48 hours). Two patients had undergone reexploration for bleeding on postoperative day (POD) 2 and another patient underwent angiographic coil embolization for GDA stump bleeding on POD 4. According to Clavien–Dindo’s classification, only two patients in the OPD group had Grade III complications that necessitated surgical intervention, and no significant differences were noted in the incidence of postoperative complications between the two groups. There was one (3.3%) 30-day mortality in the OPD group. One death occurred on POD 3 in a patient who underwent OPD for T3N2M0 with sepsis and disseminated intravascular coagulation. Overall severe complications did not significantly differ between the two groups. Although the differences in abdominal infections were not statistically significant between the two groups (30% vs. 40%, p = 0.417), the LAPD group had a lesser incidence and severity. Three cases in the LAPD group underwent conversion to OPD, two cases with suspected portal vein involvement, and one case with uncontrolled hemorrhage during uncinate dissection.

Table 3 . Comparison of short-term complications and surgical outcomes between LAPD and OPD after propensity matching

ParameterLAPD (n = 30)OPD (n = 30)p-value
Grade A20 (66.7)19 (63.3)0.787
Grade B9 (30.0)10 (33.3)0.781
Grade A0 (0)3 (10.0)0.237
DGE20 (66.7)25 (83.3)0.136
Grade A11 (36.7)10 (33.3)0.787
Grade B9 (30.0)15 (50.0)0.114
Grade > III9 (30.0)15 (50.0)0.08
Radiological intervention for intrabdominal collection9 (30.0)13 (43.3)0.284
Bile leak2 (6.7)2 (6.7)0.997
Pulmonary infection3 (10.0)5 (16.7)0.704
Abdominal collection9 (30.0)13 (43.3)0.417
Wound infection12 (40.0)12 (40.0)0.998
Re-exploration0 (0)2 (6.7)0.492
30-day mortality0 (0)1 (3.3)0.998

Values are presented as number (%).

LAPD, laparoscopic assisted pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; POPF, postoperative pancreatic fistula; PPH, post pancreatectomy hemorrhage; DGE, delayed gastric emptying.

While there were variations in tumor size, grade, pathological type, AJCC T, and N staging, perineural invasion, lymphatic spread, and R0 resection, no statistically significant changes were seen in TNM staging or pathological outcomes. Two patients in the OPD group had positive pancreatic resection margin (adenocarcinoma). The total number of lymph nodes harvested did not differ between the two groups (LAPD, 12 vs. 14, p = 0.620). Five patients in the LAPD group and seven patients in the OPD group had perineural invasion, which can influence long-term survival. Additional histopathological outcomes are shown in Table 4.

Table 4 . Comparison of TNM staging and pathologic outcomes between the LAPD group and OPD group of unmatched and matched groups

ParameterLAPD (n = 30)OPD (n = 62)p-valueLAPD (n = 30)OPD (n = 30)p-value
Tumor size (cm)
< 14 (13.3)10 (16.1)0.9684 (13.3)5 (16.7)0.996
1–27 (23.3)17 (27.4)0.6767 (23.3)8 (26.7)0.766
> 219 (63.3)35 (56.5)0.53019 (63.3)17 (56.7)0.598
Pathological type0.8480.881
Intestinal21 (70.0)38 (61.2)21 (70.0)22 (73.3)
Pancreaticobiliary4 (13.3)12 (19.3)4 (13.3)5 (16.6)
Mixed3 (10.0)8 (12.9)3 (10.0)2 (6.6)
Mucinous adenocarcinoma2 (6.6)4 (6.5)2 (6.6)1 (3.3)
AJCC T staging0.955 0.650
T16 (20.0)12 (19.3)6 (20.0)4 (13.3)
T215 (50.0)33 (53.2)15 (50.0)14 (46.6)
T39 (30.0)17 (27.4)9 (30.0)12 (40.0)
AJCC N staging0.1690.145
N024 (80.0)40 (64.5)24 (80.0)19 (63.3)
N16 (20.0)17 (27.4)6 (20.0)8 (26.6)
N20 (0)5 (8.1)0 (0)3 (10.0)
Perineural invasion5 (16.6)16 (25.8)0.3285 (16.6)7 (23.3)0.519
Lymphovascular invasion3 (10.0)12 (19.3)0.2553 (10.0)6 (20.0)0.278
Tumor grade
Well14 (46.7)23 (37.1)0.38014 (46.7)10 (33.3)0.292
Moderate16 (53.3)39 (62.9)0.38016 (53.3)20 (66.7)0.292
Median number of lymph nodes harvested12 (8–24)13 (6–25)0.66712 (8–24)14 (6–24)0.620
Node positive6 (20.0)21 (33.9)0.1716 (20.0)11 (36.7)0.152
R0 resection30 (100)59 (95.2)0.54830 (100)28 (93.3)0.492

Values are presented as number (%) or mean (range).

LAPD, laparoscopic assisted pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; AJCC, American Joint Committee on Cancer.


Pancreaticoduodenectomy is one of the most complex surgical procedures primarily due to the involvement of intricate anastomosis. The most frequently encountered complication following PD is POPF, often resulting from difficulties in establishing a secure pancreatoenteric anastomosis. Even though very few institutions have adopted the minimally invasive approach for PAC there has been a notable upsurge in the utilization of minimally invasive pancreaticoduodenectomy (MIPD) over the past decade. However, MIPD continues to lag behind in popularity when compared to the laparoscopic distal pancreatectomy. TLPD is a technically challenging procedure, carrying an increased risk of complications such as POPF and bile leaks, particularly when ensuring secure completion of pancreatic and biliary anastomoses. Despite the growing interest in MIPD, a definitive learning curve for the procedure has yet to be clearly defined [21]. The concept of laparoscopic PD was initially introduced by Gagner and Pomp in 1994 [22]. After the initial case report, several studies [8,23-25] have examined the outcomes of minimally invasive approaches and highlighted their advantages, including shorter hospital stays and reduced blood loss. In the current literature, three randomized controlled trials (RCTs) have been published, with one of them, the LEOPARD-2 trial, revealing a statistically significant higher complication-related deaths that were associated with the laparoscopic approach [9,11,26]. Consequently, the study was prematurely halted, prompting the authors to advise a cautious consideration of laparoscopic PD in certain cases. Another RCT, conducted by Palanivelu et al. [11] compared laparoscopic to OPD for periampullary tumors, and was underpowered to detect differences in complication rates. It is important to note that single-layer anastomoses in pancreatojejunostomy have been identified as a risk factor for POPF in MIPD. Such anastomoses are also associated with longer operative times and a 10% higher rate of Grade B/C POPF [27].

LAPD is a hybrid surgical technique that involves laparoscopic dissection, specimen mobilization with lymphadenectomy, and extracorporeal anastomosis through a small upper midline incision. This approach leverages the advantages of laparoscopic mobilization and extracorporeal anastomosis, which can reduce the risk of anastomotic leaks. The current study compared the perioperative and pathological outcomes of LAPD and OPD. Precise patient selection plays a pivotal role in ensuring the safety and success of LAPD. Based on our initial findings, early-stage ampullary adenocarcinomas and cholangiocarcinomas are the most suitable candidates for laparoscopic procedures. Additionally, patients with early pancreatic head carcinoma, particularly those without vascular involvement and tumors measuring less than 3 cm in size, are also potential candidates for laparoscopic surgery.

In our study, LAPD proved to be safe, feasible, and equally effective as open OPD. LAPD can serve as a valuable transitional step in the learning curve toward achieving a TLPD. In this study, LAPD was associated with a longer operative time compared to OPD (463.80 ± 40.94 minutes vs. 359.00 ± 45.89 minutes, p < 0.001). Laparoscopic pancreatic surgery often demands more time, particularly in the initial stages of the learning curve. Similarly, other comparative studies between LAPD and OPD have shown long intraoperative time in MIPD and a high conversion rate owing to the complexity of the procedure [14,28,29]. Operative times for LAPD have been documented to vary from 342 to 512 minutes. However, with increased experience, both the duration of the procedure and blood loss have significantly decreased within the LAPD group, as observed in our study. In our study, three cases of LAPD required conversion to OPD with two cases suspicious of portal vein involvement and one case with hemorrhage during uncinate process dissection. The conversion rate to OPD ranges from 0% to 40%, with an average of 9.1% [30-33]. Tumor adhesion to the peripancreatic vascular structures and uncontrolled bleeding during uncinate dissection were the main reasons for conversion from LAPD to OPD. Several studies have highlighted the reduced intraoperative blood loss and transfusion requirements in the MIPD group, attributed to the selection of smaller tumors and improved hemostasis facilitated by magnified vision in MIPD [21]. However, our study did not show any significant difference in intraoperative blood loss. The advantages of MIPD were most evident in the postoperative phase, with consistent findings aligning with other studies. MIPD offers benefits such as early ambulation, decreased need for analgesia, rapid return of bowel function, and reduced wound complications. These advantages contribute to improved pulmonary ventilation and quicker recovery. Patients who underwent LAPD experienced a shorter incision length, reduced postoperative pain, earlier initiation of oral intake, and shorter hospital stays (p < 0.001).

POPF is the most frequently encountered complication following PD, with reported incidence rates ranging from 3% to 45%. In MIPD, the incidence of POPF tends to be slightly higher due to the inherent challenges of achieving precise anastomosis using laparoscopy. Dokmak et al. [34] were the first to demonstrate a significant increase in morbidity with the laparoscopic approach, particularly in a higher incidence of Grade C POPF and postoperative bleeding. They even suggested that laparoscopic PD should be considered primarily for patients at low risk for pancreatic complications. To address this concern, we included LAPD in our study, where the anastomotic technique was similar in both LAPD and OPD groups. Clinically significant Grade B POPF occurred in 19 patients, with 9 in the LAPD group and 10 in the OPD group (p = 0.781). No Grade C POPF was reported in either group. There were also no significant differences in the rates of PPH, with nil in the LAPD and three cases in the OPD group (p = 0.237). DGE is the second most common complication after PD. Some studies have reported that the incidences of postoperative ileus and DGE are lower in MIPD compared to OPD, potentially due to the minimal manipulation of the bowel and reduced postoperative adhesions [23]. In our study, DGE was more common in OPD than LAPD, although this difference was not statistically significant (20 vs. 25, p = 0.136). The impact of minimally invasive surgery on the incidence of postoperative pneumonia remains unclear. Few postoperative pulmonary complications have been reported after laparoscopic surgery in the existing literature [35,36]. In our study, we reported 8 cases of postoperative pneumonia, although this difference was not statistically significant (3 cases in the LAPD group vs. 5 cases in the OPD group, p = 0.704). Overall, no significant differences in short-term complications were observed between the two groups. The mortality rate in previous studies varies from 1.6% to 8% [37-40]. However, in our LAPD group, no mortality occurred, which may be attributed to the low incidence of Grade B POPF. The median duration of hospitalization in the LAPD group was 8 days, falling within a lower range compared to the reported literature (typically ranging from 9 to 12 days) [40-42].

Previous meta-analyses of comparative studies have consistently demonstrated satisfactory oncologic outcomes, such as R0/R1 resection rates and lymph node yield, following LAPD compared to OPD in patients with malignant conditions [43]. In terms of oncological outcomes, our study found no statistically significant differences in tumor grade, the number of harvested lymph nodes, or margin status, which aligns with the findings of previous studies [43]. R0 resection, particularly at critical margins like the retroperitoneal margin and superior mesenteric artery margin, along with a favorable lymph nodal status, are considered the most crucial prognostic factors following PD. The incidence of R1 resection after PD for pancreatic head and periampullary malignancies has been reported to vary widely, ranging from 2% to 75% [44,45]. These discrepancies may be attributed to variations in pathological protocols and the inclusion of a diverse range of cases. Notably, previous studies on LAPD have shown a lower incidence of R1 resection, often attributed to the inclusion of patients with smaller diameters and early lesions. In our study, R0 resection was achieved in all cases within the LAPD group, whereas two cases in the OPD group resulted in R1 resection. The median number of lymph nodes harvested from the resected specimens was 12 (ranging from 8 to 24) in the LAPD group and 14 (ranging from 6 to 24) in the OPD group (p = 0.620). This reinforces the similarity in oncological outcomes between the two groups.

Based on the available evidence TLPD is a viable alternative for OPD but it remains a technically challenging and demanding technique that cannot be readily embraced. Our current study has demonstrated that LAPD can serve as a safe and effective bridge to overcome the learning curve necessary for TLPD. This aligns with previous reports comparing LAPD and OPD. In addition, an organized training program should remain an integral part of achieving expertise in TLPD. This program should encompass predefined milestones, planned conversion strategies, and a gradual expansion of the criteria that define eligible patient selections. Simultaneously, the implementation of an enhanced recovery protocol should run in parallel with the adoption of the LAPD approach for complex pancreatic surgeries. Both of these components are now firmly integrated into our institution’s standard operating procedures. It is important to note that, since all surgeries were performed in a high-volume institution by experienced pancreatic surgeons who have already surmounted the learning curve, the results of our current study may not be generalizable to all pancreatic surgeons and low-volume centers. Selection bias is inherent to the retrospective nature of this study. Although we have made efforts to mitigate this bias through propensity score matching, the retrospective design makes it less comparable to a RCT. This being a single-center study with a relatively short follow-up period, future research should place greater emphasis on investigating long-term outcomes, including survival, recurrences, and the quality of life for patients undergoing these procedures.


LAPD demonstrates a favorable safety profile, technical feasibility, and short-term oncological efficacy, making it a viable option for bridging the learning curve to TLPD. This minimally invasive approach can serve as a valuable step in the process of gaining expertise about the more challenging TLPD. However, despite these promising results, there remains a significant gap in our understanding of the comprehensive advantages and limitations of LAPD. To address this knowledge gap and provide a more comprehensive evaluation of the LAPD, it is imperative to conduct an RCT that systematically compares the LAPD with OPD. These studies should consider the long-term impact on patient recovery and oncological outcomes.




No potential conflict of interest relevant to this article was reported.


Conceptualization: UA, KP. Data curation: RK, AA. Methodology: RK. Writing - original draft: BNS, KK, RK. Writing - review & editing: SY, SA.

  1. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of vater. Ann Surg 1935;102:763-779.
    Pubmed KoreaMed CrossRef
  2. Whipple AO. Observations on radical surgery for lesions of the pancreas. Surg Gynecol Obstet 1946;82:623-631.
  3. Kendrick ML, van Hilst J, Boggi U, de Rooij T, Walsh RM, Zeh HJ, et al. Minimally invasive pancreatoduodenectomy. HPB (Oxford) 2017;19:215-224.
    Pubmed CrossRef
  4. Wei H, Wei B, Zheng Z, Huang Y, Huang J, Fang J. [Comparative study of outcomes after laparoscopic versus open pancreaticoduodenectomy]. Zhonghua Wei Chang Wai Ke Za Zhi 2014;17:465-468. Chinese.
  5. Lau K, Salami A, Barden G, Khawja S, Castillo DL, Poppelaars V, et al. The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the Veterans Affairs system. JAMA Surg 2014;149:1153-1161.
    Pubmed CrossRef
  6. Schmidt CM, Turrini O, Parikh P, House MG, Zyromski NJ, Nakeeb A, et al. Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg 2010;145:634-640.
    Pubmed CrossRef
  7. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13.
    Pubmed CrossRef
  8. Ricci C, Casadei R, Taffurelli G, Pacilio CA, Ricciardiello M, Minni F. Minimally invasive pancreaticoduodenectomy: what is the best "choice"? A systematic review and network meta-analysis of non-randomized comparative studies. World J Surg 2018;42:788-805.
    Pubmed CrossRef
  9. Poves I, Burdío F, Morató O, Iglesias M, Radosevic A, Ilzarbe L, et al. Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: the PADULAP randomized controlled trial. Ann Surg 2018;268:731-739.
    Pubmed CrossRef
  10. Adam MA, Choudhury K, Dinan MA, Reed SD, Scheri RP, Blazer DG, et al. Minimally invasive versus open pancreaticoduodenectomy for cancer: practice patterns and short-term outcomes among 7061 patients. Ann Surg 2015;262:372-377.
    Pubmed CrossRef
  11. Palanivelu C, Senthilnathan P, Sabnis SC, Babu NS, Srivatsan Gurumurthy S, Anand Vijai N, et al. Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg 2017;104:1443-1450.
    Pubmed CrossRef
  12. Tian F, Wang YZ, Hua SR, Liu QF, Guo JC. Laparoscopic assisted pancreaticoduodenectomy: an important link in the process of transition from open to total laparoscopic pancreaticoduodenectomy. BMC Surg 2020;20:89.
    Pubmed KoreaMed CrossRef
  13. Son TQ, Hoc TH, Quyet NT, Giang TB, Hung NN, Tung TT, et al. Efficacy of laparoscopic-assisted pancreaticoduodenectomy in Vietnamese patients with periampullary of Vater malignancies: a single-institution prospective study. Ann Med Surg (Lond) 2021;69:102742.
    Pubmed KoreaMed CrossRef
  14. Cho A, Yamamoto H, Nagata M, Takiguchi N, Shimada H, Kainuma O, et al. Comparison of laparoscopy-assisted and open pylorus-preserving pancreaticoduodenectomy for periampullary disease. Am J Surg 2009;198:445-449.
    Pubmed CrossRef
  15. Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 2017;15:1028-1061.
    Pubmed CrossRef
  16. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 2017;161:584-591.
    Pubmed CrossRef
  17. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761-768.
    Pubmed CrossRef
  18. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007;142:20-25.
    Pubmed CrossRef
  19. Adsay NV, Basturk O, Saka B, Bagci P, Ozdemir D, Balci S, et al. Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors. Am J Surg Pathol 2014;38:480-493.
    Pubmed KoreaMed CrossRef
  20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-483.
    Pubmed CrossRef
  21. Kendrick ML, Cusati D. Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience. Arch Surg 2010;145:19-23.
  22. Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc 1994;8:408-410.
    Pubmed CrossRef
  23. Zhao Z, Yin Z, Hang Z, Ji G, Feng Q, Zhao Q. A systemic review and an updated meta-analysis: minimally invasive vs open pancreaticoduodenectomy. Sci Rep 2017;7:2220.
    Pubmed KoreaMed CrossRef
  24. Deichmann S, Bolm LR, Honselmann KC, Wellner UF, Lapshyn H, Keck T, et al. Perioperative and long-term oncological results of minimally invasive pancreatoduodenectomy as hybrid technique - a matched pair analysis of 120 cases. Zentralbl Chir 2018;143:155-161.
    Pubmed KoreaMed CrossRef
  25. Pędziwiatr M, Małczak P, Pisarska M, Major P, Wysocki M, Stefura T, et al. Minimally invasive versus open pancreatoduodenectomy-systematic review and meta-analysis. Langenbecks Arch Surg 2017;402:841-851.
    Pubmed KoreaMed CrossRef
  26. van Hilst J, de Rooij T, Bosscha K, Brinkman DJ, van Dieren S, Dijkgraaf MG, et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol 2019;4:199-207.
    Pubmed CrossRef
  27. Klompmaker S, van Hilst J, Wellner UF, Busch OR, Coratti A, D'Hondt M, et al. Outcomes after minimally-invasive versus open pancreatoduodenectomy: a pan-european propensity score matched study. Ann Surg 2020;271:356-363.
    Pubmed CrossRef
  28. Kuroki T, Adachi T, Okamoto T, Kanematsu T. A non-randomized comparative study of laparoscopy-assisted pancreaticoduodenectomy and open pancreaticoduodenectomy. Hepatogastroenterology 2012;59:570-573.
    Pubmed CrossRef
  29. Suzuki O, Kondo S, Hirano S, Tanaka E, Kato K, Tsuchikawa T, et al. Laparoscopic pancreaticoduodenectomy combined with minilaparotomy. Surg Today 2012;42:509-513.
    Pubmed CrossRef
  30. Zeh HJ, Zureikat AH, Secrest A, Dauoudi M, Bartlett D, Moser AJ. Outcomes after robot-assisted pancreaticoduodenectomy for periampullary lesions. Ann Surg Oncol 2012;19:864-870.
    Pubmed CrossRef
  31. Chalikonda S, Aguilar-Saavedra JR, Walsh RM. Laparoscopic robotic-assisted pancreaticoduodenectomy: a case-matched comparison with open resection. Surg Endosc 2012;26:2397-2402.
    Pubmed CrossRef
  32. Wellner UF, Küsters S, Sick O, Busch C, Bausch D, Bronsert P, et al. Hybrid laparoscopic versus open pylorus-preserving pancreatoduodenectomy: retrospective matched case comparison in 80 patients. Langenbecks Arch Surg 2014;399:849-856.
    Pubmed CrossRef
  33. Mendoza AS 3rd, Han HS, Yoon YS, Cho JY, Choi Y. Laparoscopy-assisted pancreaticoduodenectomy as minimally invasive surgery for periampullary tumors: a comparison of short-term clinical outcomes of laparoscopy-assisted pancreaticoduodenectomy and open pancreaticoduodenectomy. J Hepato-Biliary-Pancreat Sci 2015;22:819-824.
    Pubmed CrossRef
  34. Dokmak S, Ftériche FS, Aussilhou B, Bensafta Y, Lévy P, Ruszniewski P, et al. Laparoscopic pancreaticoduodenectomy should not be routine for resection of periampullary tumors. J Am Coll Surg 2015;220:831-838.
    Pubmed CrossRef
  35. Bablekos GD, Roussou T, Rasmussen T, Vassiliou MP, Behrakis PK. Postoperative changes on pulmonary function after laparoscopic and open cholecystectomy. Hepatogastroenterology 2003;50:1193-1200.
  36. Cone MM, Herzig DO, Diggs BS, Rea JD, Hardiman KM, Lu KC. Effect of surgical approach on 30-day mortality and morbidity after elective colectomy: a NSQIP study. J Gastrointest Surg 2012;16:1212-1217.
    Pubmed CrossRef
  37. Wang Y, Bergman S, Piedimonte S, Vanounou T. Bridging the gap between open and minimally invasive pancreaticoduodenectomy: the hybrid approach. Can J Surg 2014;57:263-270.
    Pubmed KoreaMed CrossRef
  38. Zureikat AH, Breaux JA, Steel JL, Hughes SJ. Can laparoscopic pancreaticoduodenectomy be safely implemented? J Gastrointest Surg 2011;15:1151-1157.
    Pubmed CrossRef
  39. Asbun HJ, Stauffer JA. Laparoscopic vs open pancreaticoduodenectomy: overall outcomes and severity of complications using the Accordion Severity Grading System. J Am Coll Surg 2012;215:810-819.
    Pubmed CrossRef
  40. Wang M, Peng B, Liu J, Yin X, Tan Z, Liu R, et al. Practice patterns and perioperative outcomes of laparoscopic pancreaticoduodenectomy in China: a retrospective multicenter analysis of 1029 patients. Ann Surg 2021;273:145-153.
    Pubmed CrossRef
  41. Nassour I, Wang SC, Christie A, Augustine MM, Porembka MR, Yopp AC, et al. Minimally invasive versus open pancreaticoduodenectomy: a propensity-matched study from a national cohort of patients. Ann Surg 2018;268:151-157.
    Pubmed CrossRef
  42. Lu C, Jin W, Mou YP, Zhou J, Xu X, Xia T, et al. Analysis of learning curve for laparoscopic pancreaticoduodenectomy. J Vis Surg 2016;2:145.
    Pubmed KoreaMed CrossRef
  43. Vladimirov M, Bausch D, Stein HJ, Keck T, Wellner U. Hybrid laparoscopic versus open pancreatoduodenectomy. A meta-analysis. World J Surg 2022;46:901-915.
    Pubmed KoreaMed CrossRef
  44. Fatima J, Schnelldorfer T, Barton J, Wood CM, Wiste HJ, Smyrk TC, et al. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 2010;145:167-172.
    Pubmed CrossRef
  45. Hakeem AR, Verbeke CS, Cairns A, Aldouri A, Smith AM, Menon KV. A matched-pair analysis of laparoscopic versus open pancreaticoduodenectomy: oncological outcomes using Leeds Pathology Protocol. Hepatobiliary Pancreat Dis Int 2014;13:435-441.
    Pubmed CrossRef


May 2024, 28 (2)